Cargando…

Significance of Liver Zonation in Hepatocellular Carcinoma

Liver zonation is fundamental to normal liver function, and numerous studies have investigated the microstructure of normal liver lobules. However, only a few studies have explored the zonation signature in hepatocellular carcinoma (HCC). In this study, we investigated the significance of liver zona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Shizhe, Gao, Jie, Wang, Haoren, Liu, Long, Liu, Xudong, Xu, Yuantong, Shi, Jihua, Guo, Wenzhi, Zhang, Shuijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260020/ https://www.ncbi.nlm.nih.gov/pubmed/35813194 http://dx.doi.org/10.3389/fcell.2022.806408

Ejemplares similares

The Prognostic Model Based on Tumor Cell Evolution Trajectory Reveals a Different Risk Group of Hepatocellular Carcinoma
por: Wang, Haoren, et al.
Publicado: (2021)

ENO3 Inhibits Growth and Metastasis of Hepatocellular Carcinoma via Wnt/β-Catenin Signaling Pathway
por: Cui, Honglei, et al.
Publicado: (2021)

Identification of Context-Specific Fitness Genes Associated With Metabolic Rearrangements for Prognosis and Potential Treatment Targets for Liver Cancer
por: Yu, Shizhe, et al.
Publicado: (2022)

Metabolic and non-metabolic liver zonation is established non-synchronously and requires sinusoidal Wnts
por: Ma, Ruihua, et al.
Publicado: (2020)

Combined DNA Methylation and Transcriptomic Assessments to Determine a Prognostic Model for PD-1-Negative Hepatocellular Carcinoma
por: Zhu, Lixu, et al.
Publicado: (2021)

MCM3AP-AS1: An Indispensable Cancer-Related LncRNA
por: Yu, Xiao, et al.
Publicado: (2021)

Current Research Progress of the Role of LncRNA LEF1-AS1 in a Variety of Tumors
por: Zheng, Qingyuan, et al.
Publicado: (2021)

Functional and Clinical Characteristics of Cell Adhesion Molecule CADM1 in Cancer
por: Li, Hongxu, et al.
Publicado: (2021)

Bioinformatics Study Revealed Significance of Exosome Transcriptome in Hepatocellular Carcinoma Diagnosis
por: Wu, Zeng-Hong, et al.
Publicado: (2022)

A Prognostic Model of Pancreatic Cancer Based on Ferroptosis-Related Genes to Determine Its Immune Landscape and Underlying Mechanisms
por: Yu, Xiao, et al.
Publicado: (2021)

Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine
por: Xu, Yating, et al.
Publicado: (2021)

An Integrated Fibrosis Signature for Predicting Survival and Immunotherapy Efficacy of Patients With Hepatocellular Carcinoma
por: Liu, Long, et al.
Publicado: (2021)

Identification of Therapeutic Targets and Prognostic Biomarkers Among Chemokine (C-C Motif) Ligands in the Liver Hepatocellular Carcinoma Microenvironment
por: Jiang, Zhongyi, et al.
Publicado: (2021)

Emerging Regulatory Mechanisms Involved in Liver Cancer Stem Cell Properties in Hepatocellular Carcinoma
por: Lv, Duoduo, et al.
Publicado: (2021)

Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

CD8+ T cell trajectory subtypes decode tumor heterogeneity and provide treatment recommendations for hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2022)

Identification of PANoptosis-relevant subgroups to evaluate the prognosis and immune landscape of patients with liver hepatocellular carcinoma
por: Zhang, Zhengwei, et al.
Publicado: (2023)

Identification of the Pyroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Hepatocellular Carcinoma
por: Liu, Shuang, et al.
Publicado: (2021)

Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma
por: Xing, Zhe, et al.
Publicado: (2022)

BAP31 Promotes Tumor Cell Proliferation by Stabilizing SERPINE2 in Hepatocellular Carcinoma
por: Zhang, Xiyang, et al.
Publicado: (2020)

Novel Insights in the Regulatory Mechanisms of Ferroptosis in Hepatocellular Carcinoma
por: Ma, Shiwen, et al.
Publicado: (2022)

Identification of Immune-Related Genes for Establishment of Prognostic Index in Hepatocellular Carcinoma
por: Li, Yinfang, et al.
Publicado: (2021)

The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
por: Wang, Haiyu, et al.
Publicado: (2020)

Probing Synergistic Targets by Natural Compounds for Hepatocellular Carcinoma
por: Gao, Jian, et al.
Publicado: (2021)

Comprehensive analysis to identify the neurotransmitter receptor-related genes as prognostic and therapeutic biomarkers in hepatocellular carcinoma
por: Wang, Xiaoqiang, et al.
Publicado: (2022)

FXR1 promotes proliferation, invasion and migration of hepatocellular carcinoma in vitro and in vivo
por: Zhao, Kun, et al.
Publicado: (2022)

The Critical Role of Ferroptosis in Hepatocellular Carcinoma
por: Pan, Fan, et al.
Publicado: (2022)

Increased Expression of Fibulin-1 Is Associated With Hepatocellular Carcinoma Progression by Regulating the Notch Signaling Pathway
por: Gong, Jiao, et al.
Publicado: (2020)

Identification of the Expression Patterns and Potential Prognostic Role of 5-Methylcytosine Regulators in Hepatocellular Carcinoma
por: Liu, Yong, et al.
Publicado: (2022)

A Novel Ten-Gene Signature Predicting Prognosis in Hepatocellular Carcinoma
por: Zhou, Taicheng, et al.
Publicado: (2020)

Lestaurtinib Has the Potential to Inhibit the Proliferation of Hepatocellular Carcinoma Uncovered by Bioinformatics Analysis and Pharmacological Experiments
por: Wu, Shuang, et al.
Publicado: (2022)

Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy
por: Yu, Lihua, et al.
Publicado: (2022)

Editorial: Hepatitis B virus and host interactions in liver diseases
por: Gao, Yuen, et al.
Publicado: (2023)

RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma
por: Rao, Benchen, et al.
Publicado: (2021)

Development and validation of a copper-related gene prognostic signature in hepatocellular carcinoma
por: Shi, Haoting, et al.
Publicado: (2023)

Cleavage and Polyadenylation Specific Factor 1 Promotes Tumor Progression via Alternative Polyadenylation and Splicing in Hepatocellular Carcinoma
por: Chen, Shi-lu, et al.
Publicado: (2021)

Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma
por: Xu, Dafeng, et al.
Publicado: (2021)

The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma
por: Zhao, Siqi, et al.
Publicado: (2022)

Immunometabolic factors contributing to obesity-linked hepatocellular carcinoma
por: Akl, May G., et al.
Publicado: (2023)

Exosomal miR-3682-3p Suppresses Angiogenesis by Targeting ANGPT1 via the RAS-MEK1/2-ERK1/2 Pathway in Hepatocellular Carcinoma
por: Dong, Shuang-Shuang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l555i4qb9drq2ot352gchiu43j